About

Erisyon is currently preparing to introduce the instrument in the near future. Erisyon is currently open to discuss early access as well as potential collaborations.

Erisyon has emerged from the University of Texas at Austin to commercialize the world’s first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT’s Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.

EXECUTIVES

Zack Booth Simpson

VP of Software Development & Cofounder

Angela Bardo, PhD

VP of Product Development & Cofounder

Talli Somekh

CEO & Cofounder

SCIENTIFIC ADVISORY BOARD

Jagannath Swaminathan PhD

Cofounder

Prof Eric Anslyn

Cofounder

Prof Edward Marcotte

Cofounder